 BEDFORD, Mass.--BUSINESS WIRE--- OCUL OCUTX--Please replace the release dated April 29, 2021, with the following corrected version due to multiple revisions. The updated release: OCULAR THERAPEUTIXTM TO PRESENT PRE-CLINICAL AND CLINICAL DATA AT THE 2021 ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY ARVO ANNUAL MEETING Ocular Therapeutix, Inc. NASDAQ:OCUL, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions 